The price-to-earnings ratio for Global Medical REIT Inc (NYSE: GMRE) is above average at 213.10x. The 36-month beta value for GMRE is also noteworthy at 1.18. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 1 rating it as “overweight,” 5 rating it as “hold,” and 0 rating it as “sell.”
The public float for GMRE is 63.10M, and at present, short sellers hold a 3.17% of that float. The average trading volume of GMRE on June 26, 2025 was 651.93K shares.
GMRE) stock’s latest price update
The stock price of Global Medical REIT Inc (NYSE: GMRE) has jumped by 2.46 compared to previous close of 6.51. Despite this, the company has seen a gain of 5.04% in its stock price over the last five trading days. businesswire.com reported 2025-06-23 that BETHESDA, Md.–(BUSINESS WIRE)–GLOBAL MEDICAL REIT APPOINTS MARK DECKER, JR. AS CEO.
GMRE’s Market Performance
GMRE’s stock has risen by 5.04% in the past week, with a monthly rise of 4.88% and a quarterly drop of -21.34%. The volatility ratio for the week is 3.18% while the volatility levels for the last 30 days are 2.61% for Global Medical REIT Inc The simple moving average for the last 20 days is 4.97% for GMRE’s stock, with a simple moving average of -18.47% for the last 200 days.
Analysts’ Opinion of GMRE
Many brokerage firms have already submitted their reports for GMRE stocks, with B. Riley Securities repeating the rating for GMRE by listing it as a “Neutral.” The predicted price for GMRE in the upcoming period, according to B. Riley Securities is $9 based on the research report published on April 03, 2025 of the current year 2025.
Berenberg, on the other hand, stated in their research note that they expect to see GMRE reach a price target of $11.75. The rating they have provided for GMRE stocks is “Buy” according to the report published on October 18th, 2024.
Alliance Global Partners gave a rating of “Buy” to GMRE, setting the target price at $12 in the report published on September 19th of the previous year.
GMRE Trading at -2.41% from the 50-Day Moving Average
After a stumble in the market that brought GMRE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -35.53% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GMRE starting from Decker Mark Okey Jr, who purchase 102,668 shares at the price of $6.52 back on Jun 24 ’25. After this action, Decker Mark Okey Jr now owns 102,668 shares of Global Medical REIT Inc, valued at $669,694 using the latest closing price.
Decker Mark Okey Jr, the CEO and President of Global Medical REIT Inc, purchase 57,332 shares at $6.50 during a trade that took place back on Jun 25 ’25, which means that Decker Mark Okey Jr is holding 160,000 shares at $372,834 based on the most recent closing price.
Stock Fundamentals for GMRE
Current profitability levels for the company are sitting at:
- 0.24 for the present operating margin
- 0.79 for the gross margin
The net margin for Global Medical REIT Inc stands at 0.06. The total capital return value is set at 0.03. Equity return is now at value 1.45, with 0.63 for asset returns.
Currently, EBITDA for the company is 91.47 million with net debt to EBITDA at -0.06. When we switch over and look at the enterprise to sales, we see a ratio of 3.19. The receivables turnover for the company is 17.02for trailing twelve months and the total asset turnover is 0.11. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.95.
Conclusion
In summary, Global Medical REIT Inc (GMRE) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
